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Abstract
Cell motility depends on the rapid growth of cortical actin filaments whose barbed ends are capped in the resting cell. High
speed supernates (HSS) of dilute neutrophil lysates contain actin monomers and/or oligomers that can be induced to
polymerize by certain stimuli. We questioned whether some of the actin remaining in the supernate after high speed
centrifugation exists as occult nucleation sites which can elongate when uncapped. Phosphatidylinositol-4,5-bisphosphate
(PIP2) may play a critical role as an intracellular messenger in cytoskeletal rearrangement after stimulation by removing
cappers from barbed filament ends. The experiments reported here examine the separate and interactive effects of PIP2
micelles and micromolar [Ca2] on the rates of nucleation and elongation of pyrenyl-G-actin in the presence of HSS. HSS
slowed the nucleation and elongation rates of gel-filtered pyrenyl-G-actin polymerized at submicromolar [Ca2]. Under these
conditions, PIP2 only slightly increased the number of nucleation sites, but delayed the slowing of the elongation rate in the
presence of HSS. Nucleating activity in HSS could be induced by the addition of micromolar [Ca2] and totally abolished by
immunoprecipitation of gelsolin from HSS; incubation of HSS with PIP2 at micromolar [Ca2] slightly decreased the number
of calcium-induced nucleation sites in the supernate. Incubation of HSS with PIP2 before the addition of calcium led to a
greater reduction in Ca2-inducible nucleation sites. HSS possessed more nucleation sites after simultaneous exposure to
PIP2 and Ca2, followed by chelation of Ca2 with EGTA, than HSS preincubated at micromolar [Ca2] without PIP2. At
submicromolar [Ca2], PIP2 only generated a few barbed end nucleation sites in the HSS, but lessened the gradual slowing of
elongation seen with HSS in the absence of PIP2, presumably by preventing capping by capping protein-L2 in the supernate.
Pointed end nucleating sites in HSS, attributable to gelsolin, could be created by adding micromolar [Ca2]. The
preincubation of HSS with PIP2 in the absence of micromolar [Ca2] decreased the number of Ca2-inducible nucleation sites
in the HSS. Under conditions mimicking the sequential rise and fall of cytosolic [Ca2] after stimulation, PIP2 accelerated
actin polymerization despite the inhibitory action of HSS by maintaining Ca2-activated nucleation sites. These observations
suggest that a possible role for PIP2 in modulating cytoskeletal growth in vivo may be to regulate nucleation sites activated
by sequential changes in cytosolic [Ca2]. ß 1998 Published by Elsevier Science B.V. All rights reserved.
Keywords: Phosphatidylinositol-4,5-bisphosphate; Calcium; Capping protein-L2 ; Actin
0167-4889 / 98 / $ ^ see front matter ß 1998 Published by Elsevier Science B.V. All rights reserved.
PII: S 0 1 6 7 - 4 8 8 9 ( 9 8 ) 0 0 1 0 8 - 6
* Room 274, Education and Research Building, 401 Haddon Avenue, Camden, NJ 08103, USA. Fax: +1 (609) 757-7803;
E-mail : dinubile@umdnj.edu.
BBAMCR 14380 13-10-98 Cyaan Magenta Geel Zwart
Biochimica et Biophysica Acta 1405 (1998) 85^98
1. Introduction
Despite bu¡er conditions in the cell favorable for
the polymerization of actin, nearly equivalent
amounts of cytoplasmic actin are in the monomeric
globular (G) and ¢lamentous (F) forms [1]. However,
phagocytes can quickly double the amount of F-actin
upon exposure to chemoattractants [2,3]. Since spon-
taneous nucleation at the concentrations of G-actin
present in the cytosol occurs too slowly to explain
the observed rapid rate of polymerization, the ki-
netics of cytoskeletal rearrangements after cell stim-
ulation cannot be explained simply by mobilization
of G-actin from sequestered sites. Accordingly, ago-
nists must also induce the formation of new nuclea-
tion sites for ¢lament growth [4].
Nucleation sites might be generated by activating
nucleating proteins or releasing occult nucleation
sites in the cytoplasm. Preformed nucleation sites
can be exposed by the uncapping of pre-existent ac-
tin ¢laments with or without severing. A variant of
this possibility involves increasing the availability of
actin oligomers, by uncapping and/or unbundling, to
act as seeds for ¢lament elongation [5]. Cutting of
actin ¢laments without capping is another potential
mechanism by which the number of growing ends
can be rapidly augmented.
Data in platelets suggest that new nucleation sites
may be created by the sequential action of calcium
and PIP2, ¢rst to activate gelsolin to cut pre-existent
actin ¢laments and cap the newly formed barbed
ends and then to uncap both the original and just
created ends [4,6,7]. Gelsolin as well as the resting
capper (presumed to be capping protein-L2) are si-
multaneously removed from the barbed ends by the
formation of PIP2 and the lowering of cytosolic cal-
cium [4,7].
In the neutrophil, chemoattractants rapidly lead to
an approximately two-fold increase in both the num-
ber of ¢laments and the concentration of F-actin [3].
The increase in the F-actin content after exposure of
streptolysin-O permeabilized neutrophils to GTPQS
depends on the availability of free barbed ends [8].
High speed supernates (HSS) of dilute neutrophil
lysates contain actin that can be induced to polymer-
ize under certain conditions [9] ; it is unclear whether
some of the actin remaining in the supernate after
lysis, dilution and high speed centrifugation exists as
oligomers which are capable of nucleating polymer-
ization when uncapped. The addition of cdc42
charged with GTPQS to HSS, but not GTPQS alone,
results in a quick and substantial increase in the
amount of sedimentable actin at submicromolar
[Ca2] [9] HSS exposed to micromolar [Ca2] causes
exogenous actin to polymerize without a lag phase,
presumably through gelsolin-mediated nucleation
and pointed end elongation.
We decided to study the kinetic behavior of HSS
as a ¢rst approximation for the events that may oc-
cur in the cytosol of neutrophils after stimulation by
chemoattractants. This surrogate system allowed us
to test earlier observations made on puri¢ed proteins
in the more complex milieu of multiple interacting
cytosolic components, while bypassing the barrier
of the plasma membrane [9]. Since both Ca2 and
PIP2 are widely accepted as key second messengers in
signal transduction which act directly on actin bind-
ing proteins to promote rapid polymerization [4,10^
14], we focused on the individual and interactive ef-
fects of these two mediators on the rates of actin
nucleation and subsequent elongation. Our observa-
tions revealed that when preincubated together at
submicromolar [Ca2], PIP2 reduced the number of
Ca2-inducible nucleation sites in HSS as expected,
but paradoxically maintained Ca2-induced nuclea-
tion sites after [Ca2] had been lowered.
2. Materials and methods
2.1. Procurement of rabbit neutrophils
Neutrophils were obtained from rabbit peritoneal
exudates, as described by Sullivan and Zigmond [15]
except that the animals were sedated with 0.02 mg/kg
of acepromazine maleate (Germenta, Kansas City,
MO) 20 min prior to handling.
2.2. Preparation of neutrophil lysates
Neutrophils were resuspended at 2U108 cells/ml in
a lysis bu¡er containing 10 mM HEPES, 2 mM
MgCl2, 150 mM KCl, 5 mM EGTA, 2 mM potassi-
um phosphate, 10 mM L-glycerol phosphate, 0.2 mM
dithiothreitol (DTT), 5 mM ATP, brought to pH 7.2
with NaOH. Just before lysis, protease inhibitors
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with ¢nal concentrations of 1 mM phenylmethylsul-
fonyl £uoride (PMSF), 1 Wg/ml leupeptin, 1 Wg/ml
benzamide, 10 Wg/ml aprotinin and 10 Wg/ml
TAME-HCl were added. Cells were then incubated
on ice in a Parr bomb at 350 psi of N2 for 15 min
before pressure was released [16]. The extracts cre-
ated by nitrogen cavitation were immediately spun
for 20 min at 100 000Ug (80 000 rpm in the 100.3 ro-
tor) in a Beckman TL-100 tabletop ultracentrifuge at
4‡C. This ‘HSS’ was stored at 380‡C. Typically,
HSS contained 2 mg protein/108 lysed cells. For
some experiments, neutrophils were lysed on ice in
the lysis bu¡er previously described at a concentra-
tion of 3U108 by sonication using a Dynatech Sonic
Dismembrator (model 150) for 1 s every 4^5 s for
three cycles. The sonicated extracts were spun at
14 000 rpm for 5 min in an Eppendorf 5412 centri-
fuge at 4‡C and then this supernate was spun again
in a Beckman TL-100 ultracentrifuge as detailed
above to make HSS.
2.3. Preparation of pyrenyl-G-actin
Actin was puri¢ed from acetone powder extracted
from the skeletal muscle of New Zealand white rab-
bits by the method of Spudich and Watt [17]. Pyren-
ylactin was prepared from rabbit skeletal muscle
actin as described by Murray et al. [18]. The pyren-
yl-G-actin was applied to a Sephacryl S-200 (Phar-
macia, Piscataway, NJ) gel ¢ltration column and
then maintained in a Storage bu¡er, containing
5 mM triethanolamine, 0.3 mM CaCl2, 0.68 mM
ATP, 0.1 mM ethylenediaminetetraacetic acid
(EDTA), 0.02% NaN3, pH 7.5, at 4‡C. The critical
actin monomer concentration varied between 0.1 and
0.2 WM for di¡erent preparations.
2.4. Preparation of gelsolin
Plasma gelsolin was isolated from rabbit serum
(Life Technologies, Gaithersburg, MD) as described
by Cooper [19].
2.5. Sedimentation assay and quantitative Western
blotting
Pyrenyl-G-actin at a concentration of 10 WM was
copolymerized with 3 Wl HSS from neutrophils lysed
at 2U108 cells/ml by nitrogen cavitation in 100 Wl of
either Ca- or EGTA-bu¡er for 3 h at 37‡C. Speci-
mens were then spun at 100 000Ug for 15 min at
room temperature in a Beckman Airfuge ultracentri-
fuge. The supernatants were discarded and the pellets
washed twice with 100 Wl of the corresponding bu¡-
er. The pellets were then resuspended in 30 Wl gel
sample bu¡er and applied to SDS-10% polyacryl-
amide minigels. After transfer to Immobilon-P mem-
branes (Millipore, Bedford, MA), Western blotting
was used to quantitate the amount of gelsolin and
capping protein-L2 in the pellets. Primary antibodies
were monoclonal antibodies against human plasma
gelsolin (GS-234; Sigma, St. Louis, MO) and against
capping protein-L2 (mAb 3F2.3; University of Iowa
Developmental Studies Hybridoma Bank). Peroxi-
dase-conjugated secondary antibodies (Sigma) were
detected by enhanced chemiluminescence (ECL).
ECL molecular weight markers were purchased
from Amersham, Arlington Heights, IL.
2.6. Preparation of phosphatidylinositol-4,5-
bisphosphate and other phospholipids
Phosphatidylinositol-4,5-bisphosphate (PIP2), phos-
phatidylinositol-4-monophosphate (PIP), and phos-
phatidylinositol (PI), purchased from Sigma (St.
Louis, MO), were dissolved in deionized^distilled
water at 1 mg/ml and immediately sonicated on ice
at maximum power for 3^4 min using an Ultrasonic
Cell Disrupter. Working aliquots were frozen using
liquid nitrogen and stored at 360‡C. Immediately
before use, PIP2 was thawed and sonicated on ice
at maximum power for 1 min.
2.7. Actin polymerization assay
Polymerization of pyrenyl-G-actin was determined
from the change in pyrenylactin £uorescence (excita-
tion at 370 nm; emission at 410 nm) in a Perkin-
Elmer LS5 £uorimeter. EGTA- and Ca-bu¡ers used
for the incubations and assays contained 25 mM
Tris-HCl, 138 mM KCl, 2 mM MgCl2, and 1 mM
ATP, pH 7.4 with either 1 mM EGTA or 200 WM
calcium, respectively. For selected experiments where
noted, magnesium was omitted from the EGTA-
bu¡er.
Fluorescence readings were zeroed by subtracting
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the £uorescence of pyrenyl-G-actin immediately after
its addition to polymerization bu¡er under each in-
dividual condition. Steady state was assumed to have
been reached after overnight incubation of samples
at room temperature in the dark.
2.8. Immunoprecipitation of gelsolin from HSS
GammaBind Plus Sepharose beads (Pharmacia)
were incubated overnight with phosphate-bu¡ered
saline (as a control) or monoclonal antibodies
Fig. 1. (A) High speed supernate (HSS) of dilute neutrophil lysates inhibited nucleation of pyrenyl-G-actin at submicromolar [Ca2],
but nucleated actin polymerization at micromolar [Ca2]. HSS (5 Wl) from neutrophils lysed by sonication at 3U108 cells/ml was incu-
bated in polymerization bu¡er containing either 1 mM EGTA (EGTA-bu¡er) or 0.2 mM CaCl2 (Ca-bu¡er) for 5 min at room tem-
perature. Controls contained 5 Wl of bu¡er instead of HSS. Samples were then brought to 1 ml with the corresponding bu¡er contain-
ing 1.2 WM pyrenyl-G-actin. Fluorescence was recorded at 1 min intervals for 60 min; steady-state £uorescence (shown under the
legend to the right of the ¢gure) was read after overnight incubation in the dark at room temperature. Fluorescence values were ze-
roed for each sample by subtracting the £uorescence value immediately after mixing each sample from all readings. Immunodepletion
of gelsolin from HSS removed its nucleation activity in Ca-bu¡er. (B) More gelsolin pelleted with actin copolymerized with HSS at
micromolar [Ca2], whereas more capping protein-L2 pelleted with actin copolymerized with HSS at submicromolar [Ca2]. Pyrenyl-
G-actin at a concentration of 10 WM was copolymerized with 3 Wl HSS from neutrophils lysed at 2U108 cells/ml by nitrogen cavita-
tion in 100 Wl of either Ca- or EGTA-bu¡er for 3 h at 37‡C. Specimens were then spun at 100 000Ug for 15 min at room tempera-
ture. After washing, pellets were resuspended in 30 Wl gel sample bu¡er, run on a SDS^10% polyacrylamide minigel and transferred
to Immobilon-P membranes for simultaneous immunoblotting with monoclonal antibodies against human plasma gelsolin and against
capping protein L2. Lanes 1^4 contain serial two-fold dilutions of the actin pellets polymerized in Ca-bu¡er, starting with 8 Wl ; lanes
5^8 hold the equivalent samples polymerized in EGTA-bu¡er. These results suggest competition between gelsolin and capping protein
L2 for ¢lament binding; the presence of micromolar [Ca2] favors gelsolin.
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against human plasma gelsolin (GS-234; Sigma).
After washing the beads with 1% milk and phos-
phate-bu¡ered saline, HSS was applied to each set
of beads for nearly 24 h. The next day, the beads
were spun brie£y at low speed and the supernate
recovered for Western blotting and actin nucleation
assays. This procedure generated gelsolin-depleted
HSS.
3. Results
3.1. Supernates slowed actin polymerization at
submicromolar [Ca2+], but nucleated ¢lament
growth in the presence of micromolar [Ca2+]
Actin, gelsolin and capping protein-L2 could be
demonstrated by Western blotting in the supernate
from dilute neutrophil lysates after high speed cen-
trifugation. These HSS prolonged the lag phase and
slowed the subsequent elongation rate of exogenous
pyrenyl-G-actin in polymerization bu¡er at submi-
cromolar [Ca2], but nucleated polymerization at mi-
cromolar [Ca2] (Fig. 1A).
The £uorescence ‘endpoints’ after overnight incu-
bation (shown in Fig. 1A) were nearly the same for
corresponding samples in high or low [Ca2]. How-
ever, both samples containing HSS exhibited less £u-
orescence at steady state than samples without super-
nate, a ¢nding consistent with the expected increase
in the actin monomer concentration when almost all
the barbed ends are capped by supernate. In addition
to Ca2-activated gelsolin, this explanation requires
the presence of a Ca2-independent capper in the
HSS; we had previously demonstrated su⁄cient
quantities of capping protein-L2 in dilute HSS to
cap all the barbed ends under the conditions used
here [20].
To con¢rm that barbed ¢lament ends were being
capped by HSS regardless of the [Ca2], we studied
Fig. 2. HSS slowed pyrenyl-G-actin polymerization in a dose-dependent manner, which was una¡ected by low concentrations of PIP2.
Di¡erent amounts of HSS from neutrophils lysed by nitrogen cavitation at 2U108 cells/ml were mixed with deionized^distilled water
or 12 WM PIP2 in 1 ml EGTA-bu¡er containing 1.5 WM pyrenyl-G-actin.
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Fig. 3. (A) High concentrations of PIP2 increased the pyrenyl-G-actin polymerization rate in the presence of HSS. A 5-Wl amount of
polymerization bu¡er or HSS from neutrophils lysed by sonication at 3U108 cells/ml was incubated with 45 Wl deionized^distilled
water or 450 WM PIP2 for 5 min at room temperature in EGTA-bu¡er. Samples were then bought to 1 ml with EGTA-bu¡er contain-
ing 1.2 WM pyrenyl-G-actin. Steady-state £uorescence (shown next to the legend at the right of the ¢gure) was read after overnight in-
cubation in the dark at room temperature. (B) The absence of magnesium from the incubation and assay bu¡ers did not substantially
enhance the e¡ects of PIP2 on pyrenyl-G-actin polymerization caused by HSS. A 5-Wl amount of EGTA-polymerization bu¡er or
HSS from neutrophils lysed at 2U108 cells/ml by nitrogen cavitation was incubated with 45 Wl deionized^distilled water or 450 WM
PIP2 in 100 Wl EGTA-bu¡er without magnesium for 5 min at room temperature. Samples were then bought to 1 ml with EGTA-bu¡-
er without magnesium containing 1 WM pyrenyl-G-actin. Steady-state £uorescence (shown next to the legend at the right of the ¢gure)
was read after overnight incubation in the dark at room temperature.
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the e¡ects of adding 0.5 WM cytochalasin B, a barbed
end capper (and weak nucleator of pointed end
growth) [19,21]. Cytochalasin B only slowed the poly-
merization rate in the absence of HSS. The £uores-
cence endpoints for samples containing HSS and/or
cytochalasin B were reduced, implying that the ma-
jority of barbed ends were capped if either HSS or
cytochalasin B were present. Although the kinetics of
capping di¡ered, the degree of capping at steady
state was basically equivalent in the presence of
HSS, with or without cytochalasin B, at micromolar
and submicromolar [Ca2].
The activation of gelsolin in the HSS by Ca2
would explain the observed increase in nucleation
sites with HSS at micromolar [Ca2]. Incubating
HSS with monoclonal antibodies against gelsolin
substantially reduced the Ca2-inducible nucleation
sites. Likewise, immunoprecipitation of gelsolin com-
pletely removed all nucleating activity from HSS.
Approximately twice as much gelsolin pelleted with
actin copolymerized with HSS in Ca-bu¡er as op-
posed to EGTA-bu¡er (Fig. 1B); the opposite results
were seen with capping protein L2, suggesting a com-
petitive advantage for capping by gelsolin in the
presence of micromolar [Ca2].
The inverse dependence of polymerization rate on
the concentration of HSS in EGTA-bu¡er is depicted
in Fig. 2. The decrement in steady-state £uorescence
was likewise a function of the amount of HSS added
to the sample.
3.2. PIP2 only slightly increased the nucleation rate,
but did inhibit the gradual slowing of the
elongation rate in the presence of supernate at
submicromolar [Ca2+]
As seen in Fig. 2, ‘low’ concentrations of PIP2
e¡ective in inhibiting puri¢ed capping protein and
gelsolin had no e¡ect on actin polymerization in
the presence or absence of HSS. However, high con-
Fig. 4. PIP2 had little e¡ect on the polymerization rates of pyrenyl-G-actin polymerization in the presence or absence of HSS in bu¡er
containing micromolar [Ca2]. A 5-Wl amount of Ca-bu¡er or HSS from neutrophils lysed by sonication at 3U108 cells/ml was incu-
bated with 45 Wl deionized^distilled water or 450 WM PIP2 for 5 min at room temperature in Ca-bu¡er. Samples were then bought to
1 ml with Ca-bu¡er containing 1.2 WM pyrenyl-G-actin. Steady-state £uorescence (shown next to the legend at the right of the ¢gure)
was read after overnight incubation in the dark at room temperature.
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centrations of PIP2 could reverse much of the e¡ect
of the HSS. As shown in Fig. 3A, the preincubation
of 450 WM PIP2 with HSS only slightly increased the
nucleation rate compared to either PIP2 or HSS
alone. However, the preincubation of HSS with
PIP2 more dramatically increased the later polymer-
ization rate compared to HSS not incubated with
PIP2, so that it approached the elongation rate of
the sample with PIP2 but without HSS. These obser-
vations are attributable to the capping activity of
HSS and its inhibition by high concentrations of
PIP2.
PIP2 micelles aggregate in bu¡ers containing milli-
molar [Mg2] [22]. To test whether PIP2 would in-
duce more nucleation sites in HSS in the absence of
magnesium, we repeated similar experiments to that
described in Fig. 3A except that the incubation and
assay bu¡ers did not contain magnesium. As seen by
comparing Fig. 3B to 3A, the interaction between
HSS and PIP2 was quantitatively similar in the pres-
ence or absence of magnesium. The steady-state £u-
orescence when PIP2 was incubated with HSS with-
out magnesium more closely approximated the
£uorescence endpoints in the samples without HSS
Fig. 6. PIP2 increased the number of nucleation sites in HSS when incubated in Ca-bu¡er and then assayed in EGTA-bu¡er. A 15-Wl
amount of EGTA-bu¡er or HSS from neutrophils lysed at 2U108 cells/ml by nitrogen cavitation was incubated with 45 Wl deionized^
distilled water or 450 WM PIP2 for 5 min at room temperature in Ca-bu¡er. Samples were then bought to 1 ml with EGTA-bu¡er
containing 1 WM pyrenyl-G-actin. Steady-state £uorescence (shown next to the legend at the right of the ¢gure) was read after over-
night incubation in the dark at room temperature.
Fig. 5. (A) PIP2 reduced the number of nucleation sites in HSS when incubated in EGTA-bu¡er and then assayed in bu¡er containing
micromolar [Ca2]. A 5-Wl amount of EGTA-bu¡er or HSS from neutrophils lysed by sonication at 3U108 cells/ml was incubated
with 45 Wl deionized^distilled water or 450 WM PIP2 for 5 min at room temperature in EGTA-bu¡er. Samples were then bought to
1 ml with Ca-bu¡er containing 1.2 WM pyrenyl-G-actin. Steady-state £uorescence (shown next to the legend at the right of the ¢gure)
was read after overnight incubation in the dark at room temperature. (B) The removal of magnesium from the incubation bu¡er did
not change the e¡ects of PIP2 in reducing the number of nucleation sites in HSS when incubated in EGTA-bu¡er and then assayed in
bu¡er containing micromolar [Ca2]. A 5-Wl amount of EGTA-bu¡er or HSS from neutrophils lysed at 2U108 by nitrogen cavitation
was incubated with 45 Wl deionized^distilled water or 450 WM PIP2 for 5 min at room temperature in EGTA-bu¡er without magnesi-
um. Samples were then bought to 1 ml with Ca-bu¡er containing 1.0 WM pyrenyl-G-actin. The mean £uorescence values þ the range
were plotted for two independent, but identical, experiments. Steady-state £uorescence (shown next to the legend to the right of the
¢gure) was read after overnight incubation in the dark at room temperature.
6
BBAMCR 14380 13-10-98 Cyaan Magenta Geel Zwart
M.J. DiNubile / Biochimica et Biophysica Acta 1405 (1998) 85^98 93
than when magnesium was present in the bu¡er, per-
haps attesting to the higher capacity of PIP2 micelles
in magnesium-free bu¡ers to inhibit capping by cap-
ping protein L2 [12].
3.3. Preincubation of supernate with PIP2 at
submicromolar [Ca2+] decreased the nucleation
rate when added to polymerization bu¡er with
micromolar [Ca2+]
The ability of PIP2 to a¡ect the late polymeriza-
Fig. 7. A proposed sequence of events regulating cytoskeletal growth after cell stimulation. The changes in [Ca2] and [PIP2] may be
restricted to the cell cortex near the stimulated plasma membrane. The absolute values used for [Ca2] and [PIP2] are estimates from
the literature [4,25,26]. (0) In the resting cell, where the cytosolic [Ca2] is submicromolar and [PIP2] is intermediate between its peak
(v 250 WM) and nadir (9 150 WM) levels, most of the barbed ends on cortical actin ¢laments are capped by capping protein-L2.
Nucleation and cutting by gelsolin are inhibited by the resting concentrations of both Ca2 and PIP2. (1) Stimulation of the plasma
membrane by certain agonists ¢rst leads to hydrolysis of PIP2, disinhibiting gelsolin’s activity and thus priming the system for nucle-
ation and severing. (2) IP3, generated from PIP2 hydrolysis, increases cytosolic [Ca2] and thereby activates the nucleation and sever-
ing activity of gelsolin. An increased number of shorter actin ¢laments capped by either gelsolin or capping protein-L2 are quickly
generated. (3) A rebound increase in [PIP2] to greater than its baseline concentration uncaps capped ¢lament ends (and releases poly-
merization-competent actin from monomer-sequestering proteins). Filament severing may be inhibited. Rapid ¢lament growth from
the newly freed barbed ends ensues. (4) The subsequent decline in [Ca2] in the presence of high [PIP2] prevents further ¢lament sever-
ing and shortening while maintaining free barbed ends for elongation. Under these circumstances, neither capping protein-L2 nor gel-
solin are bound to existing ¢lament ends, although gelsolin may continue to nucleate new ¢lament growth. (5) Baseline conditions are
restored; nucleation is again inhibited and barbed ends are recapped exclusively by capping protein-L2.
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tion rate when incubated and assayed at micromolar
[Ca2] was negligible, regardless of the presence of
HSS (Fig. 4). However, PIP2 did slow nucleation by
HSS to a minor degree. The same results were ob-
served when 1 WM exogenous actin was added during
the preincubation.
Compared to the calcium-containing bu¡er, incu-
bation of PIP2 and HSS in EGTA-containing bu¡er
resulted in a larger decrease in the initial polymer-
ization rate when subsequently assayed at micromo-
lar [Ca2] (Fig. 5A). Some inhibition of nucleation
by preincubating HSS and PIP2 was expected since
PIP2 decreases the nucleating capacity of puri¢ed
gelsolin under these conditions. Similar e¡ects were
found when the incubation bu¡er did not contain
magnesium (Fig. 5B). The inhibition of nucleation
was less with PIP than PIP2 ; no consistent inhibition
was demonstrable with PI (Table 1).
3.4. Preincubation of supernate with PIP2 at
micromolar [Ca2+] preserved some nucleation
sites when diluted into EGTA-containing
polymerization bu¡er without calcium
In contrast to the above results, the incubation of
HSS with PIP2 at micromolar [Ca2], followed by
diluting 10-fold into an EGTA-containing assay bu¡-
er, yielded more nucleation sites than similarly
treated HSS not exposed to PIP2 (Fig. 6). Stated
di¡erently, it appeared that the presence of high con-
centrations of PIP2 during the preincubation main-
tained nucleation sites in the HSS after chelation of
calcium with EGTA. In contrast, the preincubation
of PIP2 and HSS in polymerization bu¡er containing
micromolar [Ca2] and 1 WM actin decreased the
nucleation rate upon 10-fold dilution into an
EGTA-containing assay bu¡er, consistent with the
¢ndings depicted in Fig. 4. These data indicate
that, although less nuclei had been created in HSS
incubated with as opposed to without PIP2 at micro-
molar [Ca2], more of these nucleation sites re-
mained active after the [Ca2] had been lowered
with EGTA. Since elongation from these nuclei
could only occur from the pointed ends, we con-
¢rmed that cytochalasin B would not be expected
to slow polymerization under these conditions.
Although our other results with HSS assayed in
Ca2-bu¡er could be reproduced when puri¢ed
gelsolin was substituted for HSS, the sequential
exposure of puri¢ed gelsolin to Ca2-bu¡er with
PIP2 followed by EGTA-bu¡er did not lead to
more retained nucleation sites than in the absence
of PIP2.
4. Discussion
At submicromolar [Ca2], high concentrations of
PIP2 induce only a small increase in nucleation sites
in HSS, but can prevent capping by HSS of dilute
neutrophil lysates. As previously demonstrated using
exogenous spectrin-actin seeds as nuclei, PIP2 inhib-
its the gradual slowing of the elongation rate caused
by HSS through inhibition of capping protein-L2
[14,20]. The addition of micromolar [Ca2] to HSS
activates the nucleating activity of gelsolin, leading to
Table 1
Reduction in number of calcium-inducible nucleation sites in high speed supernates after preincubation with di¡erent phosphoinositols
Incubation condition
(all at submicromolar [Ca2])
Initial polymerization rate
HSS+phosphoinositol
Initial polymerization rate
HSS alone
Relative number of nuclei
(HSS+phosphoinositol)/
(HSS alone)
PIP2 With Mg 15.7 23.4 0.67
PIP2 Without Mg 10.4 18.7 0.56
PIP With Mg 20.0 22.4 0.89
PI With Mg 28.8 30.8 1.07
Initial polymerization rates were measured from the increase in pyrenylactin £uorescence during the ¢rst 2 min immediately following
dilution of 5 Wl HSS (from neutrophils lysed at 2U108 cells/ml by nitrogen cavitation), which had been incubated at room tempera-
ture with or without 45 Wg of sonicated phosphoinositol in 100 Wl EGTA-bu¡er in the presence or absence of magnesium for 5 min,
into 1 ml Ca-bu¡er containing 0.8 WM pryrenyl-G-actin. The relative number of nuclei were calculated as the ratio of the initial poly-
merization rate for the sample with relative to the corresponding sample without phosphoinositol. HSS, high speed supernate (of neu-
trophil extract); PIP2, phosphatidylinositol-4,5-bisphosphate; PIP, phosphatidylinositol.
BBAMCR 14380 13-10-98 Cyaan Magenta Geel Zwart
M.J. DiNubile / Biochimica et Biophysica Acta 1405 (1998) 85^98 95
‘explosive’ polymerization. The ¢nal extent of pyren-
ylactin polymerization is lower with HSS both in
the presence and absence of micromolar [Ca2], im-
plying that the large majority of barbed ¢lament
ends are capped (albeit by di¡erent cappers) at
steady state under either bu¡er condition. Exposure
of HSS to PIP2 decreases the number of calcium-
inducible nucleation sites, especially if preincubated
at submicromolar [Ca2]. Preincubation of HSS with
PIP2 at micromolar [Ca2] paradoxically maintains
some active nucleation sites after the [Ca2] has
been lowered to submicromolar levels.
The nucleating e¡ect of gelsolin requires activation
by calcium. PIP2 also modulates the binding of gel-
solin to actin monomers and ¢laments. Our data
suggest that the interactive e¡ects of these two regu-
latory mechanisms on gelsolin may not be simply
additive. Interestingly, Janmey et al. [11] had earlier
reported that gelsolin could quickly be removed from
the barbed end by EGTA only if exposed to PIP2
before capping. Others have more recently demon-
strated that the a⁄nity of gelsolin for PIP2 is in-
creased by calcium [23]. We theorize that both the
on- and o¡-rates for the binding of Ca2 to gelsolin
are slowed by PIP2. Our data are consistent with the
hypotheses that the binding of PIP2 to gelsolin can
interfere with the subsequent binding of Ca2, while
the binding of Ca2 before PIP2 may inhibit the re-
lease of Ca2 from gelsolin in HSS when [Ca2] is
later lowered by EGTA. Thus, compared to similar
conditions in the absence of PIP2, exposure of gelso-
lin in HSS to PIP2 at submicromolar [Ca2], fol-
lowed by an increase in the [Ca2] to the micromolar
range, reduces nucleation sites, whereas the coinci-
dental exposure of gelsolin to micromolar [Ca2]
and PIP2 maintains more nucleating sites after
[Ca2] is lowered. Since we could not reproduce
this latter e¡ect with puri¢ed gelsolin, a cofactor in
HSS might be required in this process.
At ¢rst glance, our data may appear to contradict
recent work by Zigmond and colleagues [9]. These
investigators showed that PIP2, even at concentra-
tions as high as 400 WM, did not a¡ect the amount
of endogenous actin in neutrophil HSS that could be
induced to polymerize by GTPQS in a EGTA-con-
taining polymerization bu¡er. Under similar assay
conditions in our experiments, PIP2 only minimally
increased the nucleation rate and extent of pyrenyl-
actin polymerization when added to HSS in the ab-
sence of micromolar [Ca2] ; its major e¡ect was to
decrease the gradual slowing of ¢lament elongation
by HSS. We also demonstrated that the nucleation of
pyrenylactin polymerization in Ca-bu¡er could be
increased or decreased by preincubating HSS with
PIP2 at micromolar or submicromolar [Ca2], respec-
tively, without signi¢cantly a¡ecting the ¢nal extent
of polymerization. One plausible ‘unifying’ hypothe-
sis for both sets of data is that the key role of PIP2 is
to modulate the rate, not the extent, of actin poly-
merization.
4.1. Limitations of studying high speed supernate of
dilute neutrophil lysates
The study of HSS can hopefully provide a cell-free
system for investigating the interactive e¡ects of actin
regulatory proteins in a complex milieu simulating
the cytosolic conditions [9]. Cells are unavoidably
perturbed by lysis and dilution, and potentially inter-
twined systems may be disrupted and partially spun
down by our protocols for producing HSS. It is cer-
tainly possible that signaling pathways in dilute HSS
‘spiked’ with pyrenyl-G-actin might not re£ect in
vivo events very closely. Nevertheless, examining
the regulation of actin ¢lament growth by HSS ex-
posed to intracellular messengers will likely yield
some novel insights beyond those already gleaned
from the study of highly puri¢ed components.
Another confounding problem in studying cell ly-
sates is that only composite e¡ects of the specimens
can be measured. Some degree of compartmentaliza-
tion may be restored by fractionating the lysate, as
we have done in preparing HSS. Since the ¢ne regu-
lation of cytoskeletal assembly likely depends in large
part on the precise localization and concentration of
both actin binding proteins and intracellular messen-
gers, speculation about the function of in vivo sys-
tems derived from the work reported here can only
be tentatively advanced in the face of these methodo-
logical limitations.
4.2. Further cautions and quali¢cations
The nucleation rate of pyrenylactin polymerization
in Ca-bu¡er was a¡ected by the [Ca2] and [PIP2]
preincubated with HSS. We have heretofore de-
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scribed these e¡ects in terms of changes in the num-
ber of competent nucleation sites in HSS under dif-
ferent conditions. An equally satisfactory explana-
tion for our observations would be a change in the
e⁄ciency of nucleation without necessarily changing
the number of sites. Thus, gelsolin may be a more or
less e¡ective nucleating protein depending on the
conditions of the preincubation to which the HSS
was subjected.
The e¡ects of the high [PIP2] used in our experi-
ments might be at least partially mediated through
PIP2-induced reductions in the concentrations of key
ions, such as K, Mg2 and Ca2. Given the rela-
tively low [PIP2] in the assay (as opposed to the in-
cubation) bu¡er and the minimal e¡ect of removing
magnesium from the assay bu¡er, potential changes
in the free [K] or [Mg2] caused by PIP2 seem un-
likely explanations for any of our observations.
Moreover, the 45 WM PIP2 present in our assays
would not be expected to lower the 200 WM calcium
in our Ca-bu¡er to submicromolar [Ca2].
Our most surprising ¢nding was that HSS sequen-
tially exposed to Ca- and then EGTA-bu¡er retained
more nucleation sites if PIP2 was present in the Ca-
bu¡er. We could not demonstrate this e¡ect using
puri¢ed gelsolin instead of HSS. Moreover, although
we ‘successfully’ reproduced this result, there were
many ‘negative’ experiments using di¡erent HSS
preparations. Whether this variability represents de-
naturing of a critical cofactor in HSS is presently
unknown. PIP2 may inhibit the binding of gelsolin
to monomeric actin in the HSS during the preincu-
bation in Ca-assay bu¡er. If free gelsolin were a more
e⁄cient actin nucleator than gelsolin^actin com-
plexes in EGTA-bu¡er, this mechanism could ac-
count for some of the observed di¡erences in nucle-
ation sites. Until we understand the determinants of
this paradoxical observation, we do not want to un-
duly emphasize its physiological signi¢cance.
4.3. Biological relevance: extrapolation and
speculation
The stimulated neutrophil must simultaneously
promote and prevent actin polymerization in border-
ing cytoskeletal domains at di¡erent times. The ki-
netics of ¢lament assembly is a function not only of
the concentration of various intracellular messengers
(e.g., Ca2 and PIP2), but also of the location and
sequence of their generation. The following undoubt-
edly oversimpli¢ed model attempts to integrate our
data into current concepts of cytoskeletal regulation
[4,7,9,12,24] (Fig. 7).
The resting neutrophil prevents actin assembly by
multiple distinct mechanisms, including capping the
barbed ends of preformed ¢laments and inhibiting
nucleation of new ¢laments. This latter task is ac-
complished by inactivating nucleating proteins as
well as decreasing the polymerization-competent
G-actin concentration to limit spontaneous nuclea-
tion. Gelsolin acts as a potent nucleator of actin
polymerization exclusively in the presence of micro-
molar [Ca2]. In addition, PIP2 can inhibit nuclea-
tion by gelsolin when mixed together before [Ca2] is
raised to micromolar levels. We theorize that PIP2
helps protect against gelsolin-nucleated ¢lament
growth if the [Ca2] is increased but [PIP2] is not
simultaneously lowered. A fall in resting [PIP2] dis-
inhibits gelsolin’s nucleating activity and primes the
system for Ca2-initiated nucleation. The subsequent
rebound in [PIP2] may not fully reverse the nucleat-
ing activity of gelsolin, but serves primarily to uncap
barbed ends blocked by capping protein-L2. Once the
[Ca2] is returned to submicromolar levels, high
[PIP2] will also uncap gelsolin-capped ¢laments.
This series of events leads to an increase in free ¢la-
ment ends by nucleating new ¢lament growth, cut-
ting pre-existing ¢laments and ultimately uncapping
barbed ends so that a new set of more numerous but
shorter ¢laments can rapidly elongate.
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